Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The use of interleukin-1-receptor antagonists in the treatment of diabetes mellitus.

× No keyword cloud information.

21 in total

Review 1. Therapeutic approaches to target inflammation in type 2 diabetes.

Authors: Allison B Goldfine; Vivian Fonseca; Steven E Shoelson
Journal: Clin Chem Date: 2010-11-22 Impact factor: 8.327

2. The evaluation of inflammatory and oxidative stress biomarkers on coffee-diabetes association: results from the 10-year follow-up of the ATTICA Study (2002-2012).

Authors: E Koloverou; D B Panagiotakos; C Pitsavos; C Chrysohoou; E N Georgousopoulou; A Laskaris; C Stefanadis
Journal: Eur J Clin Nutr Date: 2015-07-01 Impact factor: 4.016

3. [IL-1 antagonists].

Authors: I Kötter; G Horneff
Journal: Z Rheumatol Date: 2010-09 Impact factor: 1.372

Review 4. Expanding the clinical indications for α(1)-antitrypsin therapy.

Authors: Eli C Lewis
Journal: Mol Med Date: 2012-09-07 Impact factor: 6.354

5. The nuclear factor-erythroid 2-related factor/heme oxygenase-1 axis is critical for the inflammatory features of type 2 diabetes-associated osteoarthritis.

Authors: Carlos Vaamonde-Garcia; Alice Courties; Audrey Pigenet; Marie-Charlotte Laiguillon; Alain Sautet; Xavier Houard; Saadia Kerdine-Römer; Rosa Meijide; Francis Berenbaum; Jérémie Sellam
Journal: J Biol Chem Date: 2017-07-06 Impact factor: 5.157

Review 6. Immunotherapy of type 1 diabetes: where are we and where should we be going?

Authors: Xunrong Luo; Kevan C Herold; Stephen D Miller
Journal: Immunity Date: 2010-04-23 Impact factor: 31.745

7. Kinetic approach to pathway attenuation using XOMA 052, a regulatory therapeutic antibody that modulates interleukin-1beta activity.

Authors: Marina K Roell; Hassan Issafras; Robert J Bauer; Kristen S Michelson; Nerissa Mendoza; Sandra I Vanegas; Lisa M Gross; Paul D Larsen; Daniel H Bedinger; David J Bohmann; Genevieve H Nonet; Naichi Liu; Steve R Lee; Masahisa Handa; Seema S Kantak; Arnold H Horwitz; John J Hunter; Alexander M Owyang; Amer M Mirza; John A Corbin; Mark L White
Journal: J Biol Chem Date: 2010-04-21 Impact factor: 5.157

The use of interleukin-1-receptor antagonists in the treatment of diabetes mellitus.